MilestonePurity.com
Has any government agency taken action against MilestonePurity.com over GLP-1 drugs?
MilestonePurity.com is named in 1 action in this index: U.S. Attorney’s Office, Western District of Michigan, sentencing, Jul 23, 2026. Of the FDA GLP-1 warning letters and openFDA recall reports in this index as of Nov 15, 2026, none is addressed to a firm under this name.
FDA records were matched by exact name only. A firm can appear in FDA records under a different legal name.
- Websites the releases name
- milestonepurity.com
- Actions in this index
- 1
- Latest release
- Jul 23, 2026
Records
| Release | ||||
|---|---|---|---|---|
| Jul 23, 2026 | U.S. Attorney’s Office, Western District of Michigan | Sentencing | Semaglutide, Tirzepatide | justice.gov |
What each release says
- U.S. Attorney’s Office, Western District of Michigan, Jul 23, 2026, “Gobles Man Sentenced for Selling Chinese Drugs Without FDA Approval”: “www.MilestonePurity.com. Both websites claimed that the drugs were “for research purposes only” even though Piper and his co-conspirators knew that customers would be using them personally.”
Other firms named in the same releases are listed on the enforcement page.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.